ANDREA PLAUCHE: Open Payments
NPI 1518278589 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,362 in 67 payments from 15 companies in 2025. Trend: 2023 $808 · 2024 $1,550 · 2025 $1,362
Food & beverage: $1,362
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 26 | $441 |
| Janssen Pharmaceuticals, Inc | 9 | $203 |
| Axsome Therapeutics, Inc. | 7 | $173 |
| ABBVIE INC. | 5 | $98 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| Vanda Pharmaceuticals Inc. | 2 | $60 |
| Alkermes, Inc. | 2 | $54 |
| Teva Pharmaceuticals USA, Inc. | 2 | $53 |
| Lundbeck LLC | 2 | $44 |
| Collegium Pharmaceutical, Inc. | 2 | $39 |
Products named: Azstarys, Auvelity, INVEGA SUSTENNA, VRAYLAR, REXULTI, FANAPT, ARISTADA, SPRAVATO.
Industry payments across LA — which companies pay providers there.
